Overview
Product name | Recombinant Cynomolgus CLEC12A/MICL/CLL-1 Protein |
---|
Catalog No. | RP02726 |
---|
Description | Recombinant Cynomolgus CLEC12A/MICL/CLL-1 Protein is expressed from Expi293 with His tag at the N-terminal.;It contains His65-Ala265. |
---|
Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
---|
Endotoxin | Less than 1EU per μg by the LAL method. |
---|
Species | Cynomolgus |
---|
Calculated MW | 24.6 kDa |
---|
Background
CLEC12A has recently been identified as an antigen, expressed on leukemic stem cells and leukemic blasts. Given the fact that this expression profile seems stable throughout diagnosis, treatment and relapse on leukemic blasts and leukemic stem cells, CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML.
Product information
Synonym | MICL; CLL-1; CLEC12A; CLL1; DCAL2; DCAL-2; CD371; CD303; CLECSF11; CLECSF7; DLEC; HECL; PRO34150; DCAL-2 |
---|
Expression Host | HEK293 cells |
---|
Tag | N-His |
---|
Swiss-Prot | |
---|
Usage guide
Storage | Store at -20℃.Store the lyophilized protein at -20℃ to -80 ℃ up to 1 year from the date of receipt. After reconstitution, the protein solution is stable at -20℃ for 3 months, at 2-8℃ for up to 1 week. |
---|
Reconstitution | Centrifuge the tube before opening. Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. Avoid vortex or vigorously pipetting the protein. For long term storage, it is recommended to add a carrier protein or stablizer (e.g. 0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose), and aliquot the reconstituted protein solution to minimize free-thaw cycles. |
---|
* For research use only. Not for therapeutic or diagnostic purposes.